TipRanks
Advertisement
Advertisement
Biogen price target raised to $245 from $225 at Piper Sandler
PremiumThe FlyBiogen price target raised to $245 from $225 at Piper Sandler
26d ago
Biogen, Eisai announce NMPA of China approves subcutaneous Leqembi
Premium
The Fly
Biogen, Eisai announce NMPA of China approves subcutaneous Leqembi
26d ago
Stoke Therapeutics, Biogen present clinical data of Dravet syndrome candidate
Premium
The Fly
Stoke Therapeutics, Biogen present clinical data of Dravet syndrome candidate
28d ago
Biogen, Eisai announce Leqembi Iqlik now available in U.S.
PremiumThe FlyBiogen, Eisai announce Leqembi Iqlik now available in U.S.
1M ago
ProMIS Neurosciences price target lowered to $29 from $30 at Roth Capital
Premium
The Fly
ProMIS Neurosciences price target lowered to $29 from $30 at Roth Capital
1M ago
Biogen upgraded to Outperform from Peer Perform at Wolfe Research
Premium
The Fly
Biogen upgraded to Outperform from Peer Perform at Wolfe Research
1M ago
Biogen price target raised to $215 from $200 at Citi
PremiumThe FlyBiogen price target raised to $215 from $200 at Citi
2M ago
Biogen price target raised to $231 from $222 at Morgan Stanley
Premium
The Fly
Biogen price target raised to $231 from $222 at Morgan Stanley
2M ago
Biogen price target raised to $251 from $237 at H.C. Wainwright
Premium
The Fly
Biogen price target raised to $251 from $237 at H.C. Wainwright
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―